Treatment of multiple viral warts with levamisole.
Seventy-seven patients with multiple common warts were screened for a double-blind study using levamisole. Of these, only 32 patients showed cellular immune deficiency. Fourteen patients received 2.5 mg/kg, two days a week, for eight weeks, and eighteen received a placebo. Both groups showed some improvement but results were not statistically different. Placebo plays a significant role in the treatment of warts.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007111:Immunity, Cellular; D007978:Levamisole / Q000627:therapeutic use*; D014860:Warts / Q000188:drug therapy* / Q000276:immunology
D007978:Levamisole